Q2 2026 Holdings
Filed 2026-08-14 | 21 holdings | $1.7B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Kailera Therapeutics Inc(KLRA) | COMMON STOCK | 482931102 | $497.5M | 22,583,268 | 29.6% |
| Heartflow Inc(HTFL) | COM | 42238D107 | $247.9M | 8,448,158 | 14.7% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $129.0M | 3,806,566 | 7.7% |
| Savara Inc(SVRA) | COM | 805111101 | $108.4M | 17,600,621 | 6.4% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $101.5M | 1,937,938 | 6.0% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $98.0M | 9,808,819 | 5.8% |
| Pharvaris N V(PHVS) | COM | N69605108 | $92.5M | 2,675,509 | 5.5% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $88.6M | 7,085,249 | 5.3% |
| Hemab Therapeutics Holdings Inc(COAG) | COM SHS | 423494103 | $60.6M | 1,650,000 | 3.6% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $53.6M | 17,241,445 | 3.2% |
| X4 Pharmaceuticals Inc(XFOR) | COM NEW | 98420X202 | $37.2M | 7,967,454 | 2.2% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $35.3M | 362,470 | 2.1% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $33.5M | 7,171,910 | 2.0% |
| Kyverna Therapeutics Inc(KYTX) | COM | 501976104 | $25.7M | 2,885,000 | 1.5% |
| Annexon Inc(ANNX) | COM | 03589W102 | $25.3M | 4,437,731 | 1.5% |
| Rapid Micro Biosystems Inc(RPID) | CLASS A COM | 75340L104 | $14.6M | 8,434,560 | 0.9% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $10.3M | 141,234 | 0.6% |
| Atea Pharmaceuticals Inc(AVIR) | COM | 04683R106 | $9.7M | 2,075,639 | 0.6% |
| Xilio Therapeutics Inc(XLO) | COM | 98422T209 | $6.4M | 664,021 | 0.4% |
| Upstream BIO Inc(UPB) | COM | 91678A107 | $4.2M | 600,949 | 0.2% |
| Newamsterdam Pharma Company | *W EXP 99/99/999 | N62509117 | $2.1M | 99,999 | 0.1% |